As of 2026-04-11, the Relative Valuation of ChromoGenics AB (CHRO.ST) is (44.37) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 9.78 SEK, the upside of ChromoGenics AB based on Relative Valuation is -553.7%.
The range of the Relative Valuation is (37.30) - (49.79) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 22.8x | 17.4x |
| Forward P/E multiples | 11.9x - 17.7x | 14.2x |
| Fair Price | (37.30) - (49.79) | (44.37) |
| Upside | -481.4% - -609.1% | -553.7% |
| Date | P/E |